UPADACITINIB
Clinical trials for UPADACITINIB explained in plain language.
Never miss a new study
Get alerted when new UPADACITINIB trials appear
Sign up with your email to follow new studies for UPADACITINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study: does early use of upadacitinib beat rescue therapy for severe colitis?
Disease control CompletedThis study looked at 81 people with severe ulcerative colitis to see if starting upadacitinib early works better than using it after other treatments fail. Researchers checked remission rates and safety over 12 weeks. The goal is to help doctors choose the best timing for this me…
Matched conditions: UPADACITINIB
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Head-to-Head: which psoriatic arthritis drug works better in daily life?
Knowledge-focused CompletedThis study looked at 70 adults with psoriatic arthritis to compare two types of drugs—upadacitinib and IL-17 inhibitors—in everyday medical practice. Researchers tracked joint and skin symptoms over 24 weeks to see which treatment worked better. The goal is to help doctors and pa…
Matched conditions: UPADACITINIB
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC